ERA4TB:Progess and Achievements

BIOASTER is proud to be part of ERA4TB (European Regimen Accelerator for #Tuberculosis) project, a public-private initiative devoted to accelerating the development of new treatment regimens for tuberculosis. The ERA4TB...

Phage therapy at BIOASTER

#PhageTherapy at BIOASTER At @Bioaster, we have developed #preclinicalModels allowing To follow the concentration of #phages over time (#pharmacokinetics) in different fluids and organs after administration by various routes On...